Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression.

Hsu CY, Xie D, Waikar SS, Bonventre JV, Zhang X, Sabbisetti V, Mifflin TE, Coresh J, Diamantidis CJ, He J, Lora CM, Miller ER, Nelson RG, Ojo AO, Rahman M, Schelling JR, Wilson FP, Kimmel PL, Feldman HI, Vasan RS, Liu KD; CRIC Study Investigators.; CKD Biomarkers Consortium..

Kidney Int. 2017 Jan;91(1):196-203. doi: 10.1016/j.kint.2016.09.003. Epub 2016 Oct 28.

PMID:
28029431
2.

Relationship of proximal tubular injury to chronic kidney disease as assessed by urinary kidney injury molecule-1 in five cohort studies.

Waikar SS, Sabbisetti V, Ärnlöv J, Carlsson AC, Coresh J, Feldman HI, Foster MC, Fufaa GD, Helmersson-Karlqvist J, Hsu CY, Kimmel PL, Larsson A, Liu Y, Lind L, Liu KD, Mifflin TE, Nelson RG, Risérus U, Vasan RS, Xie D, Zhang X, Bonventre JV; Chronic Kidney Disease Biomarkers Consortium Investigators..

Nephrol Dial Transplant. 2016 Sep;31(9):1460-70. doi: 10.1093/ndt/gfw203. Epub 2016 Jun 7.

PMID:
27270293
3.

Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study.

Foster MC, Coresh J, Bonventre JV, Sabbisetti VS, Waikar SS, Mifflin TE, Nelson RG, Grams M, Feldman HI, Vasan RS, Kimmel PL, Hsu CY, Liu KD; CKD Biomarkers Consortium..

Clin J Am Soc Nephrol. 2015 Nov 6;10(11):1956-63. doi: 10.2215/CJN.02590315. Epub 2015 Sep 8.

4.

Cross-Disciplinary Biomarkers Research: Lessons Learned by the CKD Biomarkers Consortium.

Hsu CY, Ballard S, Batlle D, Bonventre JV, Böttinger EP, Feldman HI, Klein JB, Coresh J, Eckfeldt JH, Inker LA, Kimmel PL, Kusek JW, Liu KD, Mauer M, Mifflin TE, Molitch ME, Nelsestuen GL, Rebholz CM, Rovin BH, Sabbisetti VS, Van Eyk JE, Vasan RS, Waikar SS, Whitehead KM, Nelson RG; CKD Biomarkers Consortium..

Clin J Am Soc Nephrol. 2015 May 7;10(5):894-902. doi: 10.2215/CJN.11541114. Epub 2015 Mar 4. Review.

5.

Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus.

Fufaa GD, Weil EJ, Nelson RG, Hanson RL, Knowler WC, Rovin BH, Wu H, Klein JB, Mifflin TE, Feldman HI, Vasan RS, Kimmel PL, Kusek JW, Mauer M; CKD Biomarkers Consortium and the RASS Investigators..

Nephrol Dial Transplant. 2015 Apr;30(4):599-606. doi: 10.1093/ndt/gfv012. Epub 2015 Feb 3.

6.

Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus.

Fufaa GD, Weil EJ, Nelson RG, Hanson RL, Bonventre JV, Sabbisetti V, Waikar SS, Mifflin TE, Zhang X, Xie D, Hsu CY, Feldman HI, Coresh J, Vasan RS, Kimmel PL, Liu KD; Chronic Kidney Disease Biomarkers Consortium Investigators..

Diabetologia. 2015 Jan;58(1):188-98. doi: 10.1007/s00125-014-3389-3. Epub 2014 Oct 15.

7.

Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults.

Foster MC, Inker LA, Levey AS, Selvin E, Eckfeldt J, Juraschek SP, Coresh J; CKD Biomarkers Consortium..

Am J Kidney Dis. 2013 Jul;62(1):42-51. doi: 10.1053/j.ajkd.2013.01.016. Epub 2013 Mar 19.

8.

Setting up a PCR laboratory.

Mifflin TE.

CSH Protoc. 2007 Jul 1;2007:pdb.top14. doi: 10.1101/pdb.top14.

PMID:
21357132
9.

Genotyping of essential hypertension single-nucleotide polymorphisms by a homogeneous PCR method with universal energy transfer primers.

Bengra C, Mifflin TE, Khripin Y, Manunta P, Williams SM, Jose PA, Felder RA.

Clin Chem. 2002 Dec;48(12):2131-40.

10.

Evaluation of an automated preanalytical robotic workstation at two academic health centers.

Holman JW, Mifflin TE, Felder RA, Demers LM.

Clin Chem. 2002 Mar;48(3):540-8.

11.

Robotic automation performs a nested RT-PCR analysis for HCV without introducing sample contamination.

Mifflin TE, Estey CA, Felder RA.

Clin Chim Acta. 2000 Jan 5;290(2):199-211.

PMID:
10660810
12.

Gaucher disease: studies of phenotype, molecular diagnosis and treatment.

Rice EO, Mifflin TE, Sakallah S, Lee RE, Sansieri CA, Barranger JA.

Clin Genet. 1996 Mar;49(3):111-8.

PMID:
8737974
13.

Enzymatic and molecular diagnosis of Gaucher disease.

Barranger JA, Rice E, Sakallah SA, Sansieri C, Mifflin TE, Cooper DL.

Clin Lab Med. 1995 Dec;15(4):899-913. Review.

PMID:
8838229
14.

Molecular diagnosis of cystic fibrosis.

Kant JA, Mifflin TE, McGlennen R, Rice E, Naylor E, Cooper DL.

Clin Lab Med. 1995 Dec;15(4):877-98. Review.

PMID:
8838228
15.

Routine monitoring of temperatures inside thermal cycler blocks for quality control.

Kopp DW, Sansieri CA, Mifflin TE.

Clin Chem. 1994 Nov;40(11 Pt 1):2117-9. No abstract available.

16.

Localization of rhinovirus replication in vitro with in situ hybridization.

de Arruda E 3rd, Mifflin TE, Gwaltney JM Jr, Winther B, Hayden FG.

J Med Virol. 1991 May;34(1):38-44.

PMID:
1653307
17.

Measurement of pancreatic amylase in macroamylasaemic sera.

Mifflin TE, Bruns DE.

Ann Clin Biochem. 1991 Mar;28 ( Pt 2):197-8. No abstract available.

PMID:
1713434
18.

Use and applications of nucleic acid probes in the clinical laboratory.

Mifflin TE.

Clin Chem. 1989 Sep;35(9):1819-25. Review.

20.

Pancreatic amylase measured in serum by use of a monoclonal antibody immunochemically immobilized to a solid phase.

Mifflin TE, Hamilton M, Hubbard E, Kline MJ, Bruns DE.

Clin Chem. 1989 Jan;35(1):110-4.

Supplemental Content

Loading ...
Support Center